These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 30760587)
1. Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity. Onda M; Kobayashi K; Pastan I Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4575-4582. PubMed ID: 30760587 [TBL] [Abstract][Full Text] [Related]
2. Improving the Kaplan G; Mazor R; Lee F; Jang Y; Leshem Y; Pastan I Mol Cancer Ther; 2018 Jul; 17(7):1486-1493. PubMed ID: 29695631 [TBL] [Abstract][Full Text] [Related]
3. Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity. Leshem Y; O'Brien J; Liu X; Bera TK; Terabe M; Berzofsky JA; Bossenmaier B; Niederfellner G; Tai CH; Reiter Y; Pastan I Cancer Immunol Res; 2017 Aug; 5(8):685-694. PubMed ID: 28674083 [TBL] [Abstract][Full Text] [Related]
4. In vitro selective depletion of CD4(+)CD25(+) regulatory T-cells from PBMC using anti-tac-SAP. Akbari A; Rezaei A J Immunotoxicol; 2012; 9(4):368-73. PubMed ID: 22506556 [TBL] [Abstract][Full Text] [Related]
5. Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer. Aida K; Miyakawa R; Suzuki K; Narumi K; Udagawa T; Yamamoto Y; Chikaraishi T; Yoshida T; Aoki K Cancer Sci; 2014 Feb; 105(2):159-67. PubMed ID: 24289533 [TBL] [Abstract][Full Text] [Related]
6. Characterization of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice. Benhar I; Pastan I Clin Cancer Res; 1995 Sep; 1(9):1023-9. PubMed ID: 9816075 [TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium. Lim D; Kim KS; Kim H; Ko KC; Song JJ; Choi JH; Shin M; Min JJ; Jeong JH; Choy HE Oncotarget; 2017 Jun; 8(23):37550-37560. PubMed ID: 28473665 [TBL] [Abstract][Full Text] [Related]
8. Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. Mazor R; Eberle JA; Hu X; Vassall AN; Onda M; Beers R; Lee EC; Kreitman RJ; Lee B; Baker D; King C; Hassan R; Benhar I; Pastan I Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8571-6. PubMed ID: 24799704 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo efficacy of a recombinant immunotoxin against folate receptor beta on the activation and proliferation of rheumatoid arthritis synovial cells. Nagai T; Tanaka M; Tsuneyoshi Y; Matsushita K; Sunahara N; Matsuda T; Yoshida H; Komiya S; Onda M; Matsuyama T Arthritis Rheum; 2006 Oct; 54(10):3126-34. PubMed ID: 17009233 [TBL] [Abstract][Full Text] [Related]
10. A recombinant immunotoxin targeting CD22 with low immunogenicity, low nonspecific toxicity, and high antitumor activity in mice. Hansen JK; Weldon JE; Xiang L; Beers R; Onda M; Pastan I J Immunother; 2010 Apr; 33(3):297-304. PubMed ID: 20445350 [TBL] [Abstract][Full Text] [Related]
11. Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity. Zhou S; Chen L; Qin J; Li R; Tao H; Zhen Z; Chen H; Chen G; Yang Y; Liu B; She Z; Zhong C; Liang C PLoS One; 2013; 8(9):e73952. PubMed ID: 24023916 [TBL] [Abstract][Full Text] [Related]
12. Enhanced dendritic cell-based immunotherapy using low-dose cyclophosphamide and CD25-targeted antibody for transplanted Lewis lung carcinoma cells. Son CH; Bae JH; Lee HR; Shin DY; Yang K; Park YS J Immunother; 2015 Apr; 38(3):107-15. PubMed ID: 25751500 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients. Onda M; Nagata S; FitzGerald DJ; Beers R; Fisher RJ; Vincent JJ; Lee B; Nakamura M; Hwang J; Kreitman RJ; Hassan R; Pastan I J Immunol; 2006 Dec; 177(12):8822-34. PubMed ID: 17142785 [TBL] [Abstract][Full Text] [Related]
14. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma. Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581 [TBL] [Abstract][Full Text] [Related]
15. Depletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responses. Chen YL; Chang MC; Chen CA; Lin HW; Cheng WF; Chien CL PLoS One; 2012; 7(10):e47190. PubMed ID: 23082146 [TBL] [Abstract][Full Text] [Related]
16. Infiltration of a mesothelioma by IFN-gamma-producing cells and tumor rejection after depletion of regulatory T cells. Rudge G; Barrett SP; Scott B; van Driel IR J Immunol; 2007 Apr; 178(7):4089-96. PubMed ID: 17371963 [TBL] [Abstract][Full Text] [Related]
17. New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells. Du X; Ho M; Pastan I J Immunother; 2007 Sep; 30(6):607-13. PubMed ID: 17667524 [TBL] [Abstract][Full Text] [Related]
18. Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice. Wolf P; Alt K; Bühler P; Katzenwadel A; Wetterauer U; Tacke M; Elsässer-Beile U Prostate; 2008 Feb; 68(2):129-38. PubMed ID: 18044731 [TBL] [Abstract][Full Text] [Related]
19. Potent control of acute graft-versus-host disease lethality after immunization with a novel DNA vaccine targeted to B7-1/CD28 costimulatory signaling pathway. Luo Y; Liang F; Liu N; Xue H; Song X; Yuan F; Long J; Zhao X; Sun Y; Xi Y J Immunother; 2013 Feb; 36(2):82-92. PubMed ID: 23377669 [TBL] [Abstract][Full Text] [Related]
20. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10. Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]